NEUROSENSE THERAPEUTICS LTD NRSN

US Healthcare Pharmaceutical Preparations
$0.71
-2.1%
52w: $0.69 – $2.35

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
0.691.522.35
Jun 20, 2025 Jul 2, 2026
Institutional holders
13
+0 QoQ
13F value
$287K
+7.7% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$309K
Q1 2024
$1.9M
Q2 2024
$286K
Q3 2024
$776K
Q4 2024
$181K
Q1 2025
$964K
Q2 2025
$347K
Q3 2025
$266K
Q4 2025
$287K
Q1 2026

Number of holders

9
Q1 2024
8
Q2 2024
8
Q3 2024
14
Q4 2024
12
Q1 2025
18
Q2 2025
10
Q3 2025
13
Q4 2025
13
Q1 2026

Who owns NRSN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Yorkville Advisors Global, LP ★2Fundamental concentrated78.0K$59K0.0%-22.0%
Independent Advisor Alliance Wealth advisor50.0K$38K0.0%New
UBS Group AG Bank broker49.1K$37K0.0%+59.0%
TWO SIGMA INVESTMENTS, LP Quant stat arb44.4K$34K0.0%-13.8%
MEITAV INVESTMENT HOUSE LTD Wealth advisor40.0K$30K0.0%Held
JANE STREET GROUP, LLC Market maker28.7K$22K0.0%New
COMMONWEALTH EQUITY SERVICES, LLC Wealth advisor22.8K$17K0.0%Held
PNC FINANCIAL SERVICES GROUP, INC. Diversified mechanical21.1K$16K0.0%New
Pathstone Holdings, LLC Diversified mechanical16.5K$12K0.0%Held
GEODE CAPITAL MANAGEMENT, LLC Index provider15.9K$12K0.0%Held
Creative Planning Wealth advisor11.9K$9K0.0%Held
JONES FINANCIAL COMPANIES LLLP Wealth advisor1.0K$7310.0%Held
SBI Securities Co., Ltd. Diversified mechanical265$2000.0%-81.8%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.